Mylan announces nationwide EpiPen recall over potential defect

The original memo was due to two reports of the company's allergy treatment failing to work in emergencies.

The recall affects 13 kinds of EpiPen and EpiPen Jr. devices that were distributed between December 17, 2015 and July 1, 2016. The recalled devices may contain a defective part that could cause the pens to fail to activate.

The EpiPen 0.3 mg has an expiry date of May 2017 and lot number 5GU763.

"There will be no additional replacement-related financial burden to [patients] as a result of this recall", Mylan said.

A dozen lot numbers of EpiPens, including the specially formulated half doses known as EpiPen Jr., are included in the recall. The Mylan adult version are sold with a yellow label while the EpiPen sold with a green label.

City focused for tough Arsenal and Chelsea tests, says Garcia
If Everton are still in the hunt for the top four, their encounter with Chelsea could be decisive. City will also face Arsenal in the FA Cup semi-final at Wembley on April 23.

Mylan didn't immediately respond to a question about how many devices are affected by the recall.

The defect makes it hard for the EpiPen to work during an emergency and could have significant health consequences for someone who is experiencing an allergic reaction.

Today, though, the company is in the news again with a voluntary recall over the auto-injector devices. The new recall not only covers EpiPens sold in the USA, but also involves the children's version, known as EpiPen Jr.

The company said do not get rid of your current EpiPen until you have a replacement.

  • Ronnie Bowen